Two Sigma Investments, LP Savara Inc Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Savara Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 785,477 shares of SVRA stock, worth $1.88 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

785,477

Previous 657,849 19.4%

Holding current value

$1.88 Million

Previous $2.79 Million 13.55%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.94 - $4.07 $375,226 - $519,445	127,628 Added 19.4%	785,477 $2.41 Million
Q3 2024 Nov 14, 2024	BUY	$3.96 - $5.07 $507,949 - $650,328	128,270 Added 24.22%	657,849 $2.79 Million
Q2 2024 Aug 14, 2024	SELL	$3.66 - $5.34 $119,341 - $174,121	-32,607 Reduced 5.8%	529,579 $2.13 Million
Q1 2024 May 15, 2024	BUY	$4.19 - $5.59 $1.79 Million - $2.38 Million	426,344 Added 313.85%	562,186 $2.8 Million
Q4 2023 Feb 14, 2024	BUY	$3.18 - $4.9 $431,977 - $665,625	135,842 New	135,842 $638,000
Q1 2023 May 15, 2023	SELL	$1.6 - $2.82 $80,782 - $142,378	-50,489 Reduced 44.18%	63,783 $124,000
Q4 2022 Feb 14, 2023	SELL	$1.11 - $1.64 $8,462 - $12,503	-7,624 Reduced 6.25%	114,272 $177,000
Q3 2022 Nov 14, 2022	SELL	$1.36 - $1.88 $12,645 - $17,480	-9,298 Reduced 7.09%	121,896 $189,000
Q2 2022 Aug 15, 2022	SELL	$1.1 - $1.58 $164,550 - $236,353	-149,591 Reduced 53.28%	131,194 $199,000
Q1 2022 May 16, 2022	SELL	$1.05 - $1.36 $339,132 - $439,256	-322,983 Reduced 53.49%	280,785 $368,000
Q4 2021 Feb 14, 2022	BUY	$1.04 - $1.34 $106,091 - $136,694	102,011 Added 20.33%	603,768 $749,000
Q3 2021 Nov 15, 2021	BUY	$1.18 - $1.64 $81,224 - $112,887	68,834 Added 15.9%	501,757 $692,000
Q2 2021 Aug 16, 2021	BUY	$1.51 - $2.29 $653,713 - $991,393	432,923 New	432,923 $736,000
Q4 2020 Feb 16, 2021	SELL	$1.0 - $1.47 $25,553 - $37,562	-25,553 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.09 - $2.21 $118,134 - $239,519	-108,380 Reduced 80.92%	25,553 $28,000
Q2 2020 Aug 14, 2020	BUY	$1.8 - $3.05 $241,079 - $408,495	133,933 New	133,933 $333,000
Q4 2019 Feb 14, 2020	SELL	$0.71 - $4.91 $79,226 - $547,892	-111,587 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.16 - $3.2 $241,027 - $357,078	111,587 New	111,587 $296,000

Others Institutions Holding SVRA

# of Institutions

141

Shares Held

158M

Call Options Held

55.6K

Put Options Held

600

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $273M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Savara Inc Transaction History